Cisen Pharmaceutical Co., Ltd. logo

Cisen Pharmaceutical Co., Ltd. (603367)

Market Closed
10 Aug, 06:57
SSE SSE
¥
14. 90
-0.08
-0.534%
¥
5.97B Market Cap
- P/E Ratio
0.88% Div Yield
16.62M Volume
- Eps
¥ 14.98
Previous Close
Add Transaction
Day Range
14.77 15.2
Year Range
12.13 35.2
Want to track 603367 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603367 closed yesterday lower at ¥14.9, a decrease of -0.534% from Friday's close, completing a monthly increase of 16.5884% or ¥2.12. Over the past 12 months, 603367 stock lost -14.4661%.
603367 pays dividends to its shareholders, with the most recent payment made on Jun 03, 2026. The next estimated payment will be in In 3 months on Dec 03, 2026 for a total of ¥0.16.
The last earnings report, released on May 21, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

603367 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Cisen Pharmaceutical Co., Ltd. (603367) FAQ

What is the stock price today?

The current price is ¥14.90.

On which exchange is it traded?

Cisen Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603367.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.88%.

What is its market cap?

As of today, the market cap is 5.97B.

Has Cisen Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Cisen Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Zhenxin Du CEO
SSE Exchange
CNE100002VG4 ISIN
CN Country
3,402 Employees
3 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Cisen Pharmaceutical Co., Ltd., a prominent name in the pharmaceutical industry, operates both within China and on an international scale. The company is dedicated to the manufacture and sale of chemical drug preparations along with health care products. Initially established as Shandong Lukang Cisen Pharmaceutical Co., Ltd., it underwent a name change in 2011 to become Cisen Pharmaceutical Co., Ltd. Since its inception in 1998, the company has been based in Jining, The People's Republic of China, working towards advancing medical science and enhancing global health standards through its extensive range of pharmaceutical products.

Products and Services

Cisen Pharmaceutical Co., Ltd. offers a diverse portfolio of pharmaceutical products and services, catering to various medical needs and conditions:

  • Liver Disease Drugs: These are specialized medications designed to treat a variety of liver conditions, emphasizing on improving liver health and functionality.
  • Antitumor and Auxiliary Drugs: This category includes potent drugs used in the treatment of tumors, along with auxiliary medications that support the primary cancer treatment regimens.
  • Nutrition Preparations: These preparations are intended to supplement the nutritional needs of individuals, promoting overall health and wellness.
  • Contrast Agents: Used in medical imaging to improve the visibility of internal organs, blood vessels, or tissues, facilitating accurate diagnosis.
  • Antibiotics: Cisen Pharmaceutical provides a range of antibiotics to combat infectious diseases by inhibiting the growth of bacteria.
  • Digestive System Agents: These products are designed to treat and manage various gastrointestinal disorders, aiding in digestion and relieving discomfort.
  • Polypropylene Ampoules: This includes a variety of medications packaged in polypropylene ampoules for safe and sterile delivery.
  • External Preparations: This encompasses various topical medications for external use, including ointments, creams, and gels.
  • Sedation Anesthesia: Products under this category are aimed at inducing sedation and local or general anesthesia during medical procedures.
  • Cardiovascular: Cisen Pharmaceutical offers medications intended for the treatment and management of heart-related conditions, aiming to improve cardiovascular health.
  • Cough and Asthma: This range includes medications designed to alleviate symptoms associated with respiratory conditions such as coughs and asthma.
  • Immunomodulator: Immunomodulators are agents that modify the immune system's response to various conditions, enhancing or suppressing it as needed for therapeutic purposes.
  • Infusion: These products are intended for intravenous administration, providing essential nutrients or medications directly into the bloodstream.
  • Therapeutic Infusion Products: Similar to infusions, these products are specifically designed for therapeutic purposes, aiding in the treatment of diverse health conditions.

Contact Information

Address: No. 16 Tongji Road, Jining, China, 272073
Phone: 86 53 7298 9199